LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 69

Search options

  1. Article ; Online: Association with menopausal hormone therapy and asymptomatic gallstones in US women in the third National Health and Nutrition Examination Study.

    Jackson, Sarah S / Graubard, Barry I / Gabbi, Chiara / Koshiol, Jill

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 191

    Abstract: 15% of US adults have gallstones, most of which are clinically "silent". Several studies show that menopausal hormone therapy (MHT) increases symptomatic gallstones and cholecystectomy risk. MHT use may be contraindicated in women with gallstones and ... ...

    Abstract 15% of US adults have gallstones, most of which are clinically "silent". Several studies show that menopausal hormone therapy (MHT) increases symptomatic gallstones and cholecystectomy risk. MHT use may be contraindicated in women with gallstones and population studies may be biased by "confounding by contraindication" while the true association between MHT and gallstones remains underestimated. We sought to examine whether MHT use was associated with asymptomatic gallstones using instrumental variable (IV) analysis to account for confounding by contraindication. We used 2018 postmenopausal women from the Third National Health and Nutrition Examination Survey to estimate associations of MHT use with asymptomatic gallstones. A traditional logistic regression analysis was compared to instrumental variable (IV) analysis to account for confounding by contraindication. 12% of women with asymptomatic gallstones and 25% of women without gallstones were current MHT users (P < 0.001). The traditional analysis suggested a decreased odds of asymptomatic gallstones in current versus never users (OR 0.58, 95% CI 0.37, 0.89), but increased odds (OR 1.51, 95% CI 0.44, 5.16) in the IV analysis. The traditional analysis consistently underestimated the odds of asymptomatic gallstones with MHT use compared to the IV analysis. Accounting for confounding by contraindication, we found a suggestive, though imprecise, positive association between MHT use and asymptomatic gallstones among postmenopausal women. Failure to consider contraindication can produce incorrect results.
    MeSH term(s) Adult ; Female ; Humans ; Gallstones/epidemiology ; Gallstones/etiology ; Estrogen Replacement Therapy/adverse effects ; Nutrition Surveys ; Surveys and Questionnaires ; Menopause ; Hormone Replacement Therapy
    Language English
    Publishing date 2024-01-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-50509-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Association with menopausal hormone therapy and asymptomatic gallstones in US women in the third National Health and Nutrition Examination Study

    Sarah S. Jackson / Barry I. Graubard / Chiara Gabbi / Jill Koshiol

    Scientific Reports, Vol 14, Iss 1, Pp 1-

    2024  Volume 8

    Abstract: Abstract 15% of US adults have gallstones, most of which are clinically “silent”. Several studies show that menopausal hormone therapy (MHT) increases symptomatic gallstones and cholecystectomy risk. MHT use may be contraindicated in women with ... ...

    Abstract Abstract 15% of US adults have gallstones, most of which are clinically “silent”. Several studies show that menopausal hormone therapy (MHT) increases symptomatic gallstones and cholecystectomy risk. MHT use may be contraindicated in women with gallstones and population studies may be biased by “confounding by contraindication” while the true association between MHT and gallstones remains underestimated. We sought to examine whether MHT use was associated with asymptomatic gallstones using instrumental variable (IV) analysis to account for confounding by contraindication. We used 2018 postmenopausal women from the Third National Health and Nutrition Examination Survey to estimate associations of MHT use with asymptomatic gallstones. A traditional logistic regression analysis was compared to instrumental variable (IV) analysis to account for confounding by contraindication. 12% of women with asymptomatic gallstones and 25% of women without gallstones were current MHT users (P < 0.001). The traditional analysis suggested a decreased odds of asymptomatic gallstones in current versus never users (OR 0.58, 95% CI 0.37, 0.89), but increased odds (OR 1.51, 95% CI 0.44, 5.16) in the IV analysis. The traditional analysis consistently underestimated the odds of asymptomatic gallstones with MHT use compared to the IV analysis. Accounting for confounding by contraindication, we found a suggestive, though imprecise, positive association between MHT use and asymptomatic gallstones among postmenopausal women. Failure to consider contraindication can produce incorrect results.
    Keywords Medicine ; R ; Science ; Q
    Subject code 300
    Language English
    Publishing date 2024-01-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.

    Gabbi, Chiara / Renieri, Alessandra / Strandvik, Birgitta

    The Journal of infection

    2022  Volume 85, Issue 3, Page(s) 318–321

    Abstract: COVID-19 has shown a relevant heterogeneity in spread and fatality among countries together with a significant variability in its clinical presentation, indicating that host genetic factors may influence COVID-19 pathogenicity. Indeed, subjects carrying ... ...

    Abstract COVID-19 has shown a relevant heterogeneity in spread and fatality among countries together with a significant variability in its clinical presentation, indicating that host genetic factors may influence COVID-19 pathogenicity. Indeed, subjects carrying single pathogenic variants of the Cystic Fibrosis (CF) Transmembrane Conductance Regulator (CFTR) gene - i.e. CF carriers - are more susceptible to respiratory tract infections and are more likely to undergo severe COVID-19 with higher risk of 14-day mortality. Given that CF carrier prevalence varies among ethnicities and nations, an ecological study in 37 countries was conducted, in order to determine to what extent the diverse CF carrier geographical distribution may have affected COVID-19 spread and fatality during the first pandemic wave. The CF prevalence in countries, as indicator of the geographical distribution of CF carriers, significantly correlated in a direct manner with both COVID-19 prevalence and its Case Fatality Rate (CFR). In a regression study weighted for the number of tests performed, COVID-19 prevalence positively correlated with CF prevalence, while CFR correlated with population percentage older than 65-year, cancer and CF prevalence. Multivariate regression model also confirmed COVID-19 CFR to be associated with CF prevalence, after adjusting for elderly, cancer prevalence, and weighting for the number of tests performed. This study suggests a putative contribution of population genetics of CFTR in understanding the spatial distribution of COVID-19 spread and fatality.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/mortality ; Cystic Fibrosis/complications ; Cystic Fibrosis/epidemiology ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Genetics, Population ; Heterozygote ; Humans ; Mutation
    Chemical Substances CFTR protein, human ; Cystic Fibrosis Transmembrane Conductance Regulator (126880-72-6)
    Language English
    Publishing date 2022-06-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2022.06.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Grantsmanship writing tips: background, hypothesis and aims.

    Gabbi, Chiara / Sauer, R Michelle

    European journal of internal medicine

    2019  Volume 61, Page(s) 25–28

    MeSH term(s) Financing, Organized ; Humans ; Research Design ; United States ; Writing
    Language English
    Publishing date 2019-02-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2019.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Grantsmanship writing tips: the experimental design.

    Gabbi, Chiara / Sauer, R Michelle

    European journal of internal medicine

    2019  Volume 64, Page(s) 21–23

    MeSH term(s) Financing, Organized ; Humans ; Research Design ; United States ; Writing
    Language English
    Publishing date 2019-02-26
    Publishing country Netherlands
    Document type Editorial
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2019.02.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Drug-Induced Liver Injury - Types and Phenotypes.

    Gabbi, Chiara / Bertolotti, Marco

    The New England journal of medicine

    2019  Volume 381, Issue 14, Page(s) 1395–1396

    MeSH term(s) Chemical and Drug Induced Liver Injury ; Humans ; Phenotype
    Language English
    Publishing date 2019-09-11
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc1911063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Grantsmanship writing tips: significance, innovation and impact.

    Sauer, R Michelle / Gabbi, Chiara

    European journal of internal medicine

    2019  Volume 65, Page(s) 26–28

    MeSH term(s) Financing, Organized ; National Institutes of Health (U.S.) ; Research Design ; United States ; Writing
    Language English
    Publishing date 2019-02-23
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2019.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Reduced multidrug resistance-associated protein 2 in ticlopidine-induced cholestatic liver injury.

    Gabbi, Chiara / Bertolotti, Marco

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

    2019  Volume 52, Issue 2, Page(s) 236–238

    MeSH term(s) Aged, 80 and over ; Biomarkers/metabolism ; Chemical and Drug Induced Liver Injury/diagnosis ; Chemical and Drug Induced Liver Injury/etiology ; Cholestasis/chemically induced ; Female ; Humans ; Immunohistochemistry ; Liver/metabolism ; Liver/pathology ; Multidrug Resistance-Associated Proteins/metabolism ; Ticlopidine/adverse effects
    Chemical Substances Biomarkers ; Multidrug Resistance-Associated Proteins ; multidrug resistance-associated protein 2 (4AF605U6JN) ; Ticlopidine (OM90ZUW7M1)
    Language English
    Publishing date 2019-11-13
    Publishing country Netherlands
    Document type Case Reports ; Letter
    ZDB-ID 1459373-7
    ISSN 1878-3562 ; 1125-8055
    ISSN (online) 1878-3562
    ISSN 1125-8055
    DOI 10.1016/j.dld.2019.10.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Menopausal hormone therapy and risk of biliary tract cancers.

    Jackson, Sarah S / Pfeiffer, Ruth M / Gabbi, Chiara / Anderson, Lesley / Gadalla, Shahinaz M / Koshiol, Jill

    Hepatology (Baltimore, Md.)

    2023  Volume 75, Issue 2, Page(s) 309–321

    Abstract: Background and aims: Gallbladder cancer (GBC) has a female predominance, whereas the other biliary tract cancers (BTCs) have a male predominance, suggesting that sex hormones may be involved in carcinogenesis. We sought to evaluate the association ... ...

    Abstract Background and aims: Gallbladder cancer (GBC) has a female predominance, whereas the other biliary tract cancers (BTCs) have a male predominance, suggesting that sex hormones may be involved in carcinogenesis. We sought to evaluate the association between menopausal hormone therapy (MHT) and the risk of BTC in women.
    Approach and results: This nested case-control study was conducted in the UK Clinical Practice Research Datalink. Cases diagnosed between 1990 and 2017 with incident primary cancers of the gallbladder (GBC), cholangiocarcinoma (CCA), ampulla of Vater (AVC), and mixed type were matched to 5 controls on birth year, diagnosis year, and years in the general practice using incidence density sampling. Conditional logistic regression was used to calculate ORs and 95% CIs for associations between MHT use and BTC type. The sample consisted of 1,682 BTC cases (483 GBC, 870 CCA, 105 AVC, and 224 mixed) and 8,419 matched controls with a mean age of 73 (SD, 11) years. Combined formulations (estrogen-progesterone) were associated with an increased GBC risk (OR, 1.97; 95% CI, 1.08, 3.59). Orally administered MHT was associated with an increased GBC risk (OR, 2.28; 95% CI, 1.24, 4.17). Estrogen-only formulations (OR, 0.59; 95% CI, 0.34, 0.93) and cream or suppository administrations (OR, 0.57; 95% CI, 0.34, 0.95) were associated with decreased CCA risk. The number of prescriptions, dose, duration of use, and time since last use were not associated with GBC or CCA risk. MHT use was not associated with risk of AVC or mixed cancer.
    Conclusions: Combination MHT formulations and oral administrations were associated with increased GBC risk, whereas estrogen-only formulations were associated with a lower CCA risk. MHT formulation and administration should be carefully considered when prescribing.
    MeSH term(s) Administration, Oral ; Administration, Topical ; Aged ; Aged, 80 and over ; Ampulla of Vater ; Case-Control Studies ; Cholangiocarcinoma/epidemiology ; Common Bile Duct Neoplasms/epidemiology ; Drug Combinations ; Estrogens/therapeutic use ; Female ; Gallbladder Neoplasms/epidemiology ; Hormone Replacement Therapy ; Humans ; Incidence ; Menopause ; Middle Aged ; Neoplasms, Complex and Mixed/epidemiology ; Progesterone/therapeutic use ; Progestins/therapeutic use ; Risk Factors ; Suppositories ; United Kingdom/epidemiology
    Chemical Substances Drug Combinations ; Estrogens ; Progestins ; Suppositories ; Progesterone (4G7DS2Q64Y)
    Language English
    Publishing date 2023-03-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.32198
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Grantsmanship: What? Who? How?

    Sauer, R Michelle / Gabbi, Chiara

    European journal of internal medicine

    2018  Volume 57, Page(s) 22–24

    MeSH term(s) Financing, Organized/methods ; Humans ; Peer Review, Research ; Research Design ; Research Support as Topic
    Language English
    Publishing date 2018-11-02
    Publishing country Netherlands
    Document type Editorial
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2018.10.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top